SIGNIFICANT DIFFERENCE IN THE PROPORTION OF UNDERLYING DISEASES BETWEEN CONVENTIONAL PROTON PUMP INHIBITORS AND VONOPRAZAN REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE.

被引：0
|
作者：
Hamada, Shohei
Ihara, Eikichi
Muta, Kazumasa
Ikeda, Hiroko
Mukai, Kouzi
Otsuka, Yoshihiro
Hata, Yoshitaka
Ogino, Haruei
Chinen, Takatoshi
Ogawa, Yoshihiro
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1201
引用
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Proton Pump Inhibitors in the Management of Pediatric Gastroesophageal Reflux Disease
    Tjon, James A.
    Pe, Michael
    Soscia, Joanna
    Mahant, Sanjay
    PHARMACOTHERAPY, 2013, 33 (09): : 956 - 971
  • [42] Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors
    Tonini, M.
    Vigneri, S.
    Neri, M.
    Cuomo, R.
    Savarino, V.
    Pace, F.
    DIGESTION, 2007, 76 (3-4) : 171 - 178
  • [43] Comparison of Daily Average Consumption Between Different Proton Pump Inhibitors in Patients with Gastroesophageal Reflux Disease
    Baser, Onur
    Mody, Reema
    Xie, Lin
    Baser, Erdem
    Morlock, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S414 - S415
  • [44] Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
    Niikura, Ryota
    Yamada, Atsuo
    Hirata, Yoshihiro
    Hayakawa, Yoku
    Takahashi, Akihiro
    Shinozaki, Tomohiro
    Takeuchi, Yoshinori
    Fujishiro, Mitsuhiro
    Koike, Kazuhiko
    INTERNAL MEDICINE, 2018, 57 (17) : 2443 - 2450
  • [45] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
    Kunsch, S.
    Neesse, A.
    Linhart, T.
    Nell, C.
    Gress, T. M.
    Ellenrieder, V.
    DIGESTION, 2012, 86 (04) : 315 - 322
  • [46] Esophageal and gastric PH profiles in patients with refractory gastroesophageal reflux disease treated with twice daily proton pump inhibitors
    Boparai, Vandana
    Roorda, Andrew K.
    Marcus, Samuel N.
    Triadafilopoulos, George
    GASTROENTEROLOGY, 2007, 132 (04) : A283 - A283
  • [47] Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
    Yuan Cheng
    Jiali Liu
    Xiang Tan
    Yi Dai
    Chune Xie
    Xiaohong Li
    Qiongqiong Lu
    Fushun Kou
    Hui Jiang
    Junxiang Li
    Digestive Diseases and Sciences, 2021, 66 : 19 - 28
  • [48] Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
    Cheng, Yuan
    Liu, Jiali
    Tan, Xiang
    Dai, Yi
    Xie, Chune
    Li, Xiaohong
    Lu, Qiongqiong
    Kou, Fushun
    Jiang, Hui
    Li, Junxiang
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 19 - 28
  • [49] Efficacy of proton pump inhibitors in the treatment of gastro-esophageal reflux disease.
    Vallot, T
    Carella, G
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (1BIS): : S97 - S109
  • [50] Efficacy of Proton-Pump Inhibitors in Children With Gastroesophageal Reflux Disease: A Systematic Review
    van der Pol, Rachel J.
    Smits, Marije J.
    van Wijk, Michiel P.
    Omari, Taher I.
    Tabbers, Merit M.
    Benninga, Marc A.
    PEDIATRICS, 2011, 127 (05) : 925 - 935
12345